HU191494B - Process for producing of pipridindion derivatives and medical products consisting of such preparates - Google Patents

Process for producing of pipridindion derivatives and medical products consisting of such preparates Download PDF

Info

Publication number
HU191494B
HU191494B HU833827A HU382783A HU191494B HU 191494 B HU191494 B HU 191494B HU 833827 A HU833827 A HU 833827A HU 382783 A HU382783 A HU 382783A HU 191494 B HU191494 B HU 191494B
Authority
HU
Hungary
Prior art keywords
compound
formula
defined above
preparation
resulting
Prior art date
Application number
HU833827A
Other languages
English (en)
Hungarian (hu)
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa,Fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa,Fr filed Critical Sanofi Sa,Fr
Publication of HU191494B publication Critical patent/HU191494B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
HU833827A 1982-11-08 1983-11-08 Process for producing of pipridindion derivatives and medical products consisting of such preparates HU191494B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (1)

Publication Number Publication Date
HU191494B true HU191494B (en) 1987-02-27

Family

ID=9279000

Family Applications (1)

Application Number Title Priority Date Filing Date
HU833827A HU191494B (en) 1982-11-08 1983-11-08 Process for producing of pipridindion derivatives and medical products consisting of such preparates

Country Status (29)

Country Link
US (1) US4721710A (enExample)
EP (1) EP0110755B1 (enExample)
JP (1) JPS59161377A (enExample)
KR (1) KR900006721B1 (enExample)
AT (1) ATE22561T1 (enExample)
AU (1) AU565519B2 (enExample)
CA (1) CA1221967A (enExample)
CS (1) CS244681B2 (enExample)
DD (3) DD219770A5 (enExample)
DE (1) DE3366623D1 (enExample)
DK (1) DK511383A (enExample)
ES (1) ES8406070A1 (enExample)
FI (1) FI79536C (enExample)
FR (1) FR2535721A1 (enExample)
GR (1) GR78747B (enExample)
HU (1) HU191494B (enExample)
IE (1) IE56209B1 (enExample)
IL (1) IL70099A (enExample)
MA (1) MA19948A1 (enExample)
NO (1) NO159852C (enExample)
NZ (1) NZ206177A (enExample)
OA (1) OA07582A (enExample)
PH (1) PH20421A (enExample)
PL (3) PL140992B1 (enExample)
PT (1) PT77607B (enExample)
SG (1) SG1989G (enExample)
SU (3) SU1333237A3 (enExample)
YU (3) YU221183A (enExample)
ZA (1) ZA838065B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
AU2012255759C1 (en) 2011-05-17 2025-10-23 Principia Biopharma, Inc. Kinase inhibitors
KR102027598B1 (ko) 2011-05-17 2019-10-01 프린시피아 바이오파마, 인코퍼레이티드 타이로신 키나아제 저해제
KR102203990B1 (ko) 2012-09-10 2021-01-18 프린시피아 바이오파마, 인코퍼레이티드 키나제 저해제로서의 피라졸로피리미딘 화합물
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
ES2841248T3 (es) 2014-02-21 2021-07-07 Principia Biopharma Inc Sales y forma sólida de un inhibidor de BTK
EP3233103B1 (en) 2014-12-18 2020-10-14 Principia Biopharma Inc. Treatment of pemphigus
MA42242A (fr) 2015-06-24 2018-05-02 Principia Biopharma Inc Inhibiteurs de la tyrosine kinase
KR102391693B1 (ko) 2016-06-29 2022-04-29 프린시피아 바이오파마, 인코퍼레이티드 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-엔니트릴의 변형 방출 제제
EP4045051A1 (en) 2019-10-14 2022-08-24 Principia Biopharma Inc. Methods for treating immune thrombocytopenia by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
WO2021150723A1 (en) 2020-01-22 2021-07-29 Principia Biopharma Inc. Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
PL249749A1 (en) 1985-03-12
CA1221967A (en) 1987-05-19
DD229402A5 (de) 1985-11-06
YU184185A (en) 1986-06-30
GR78747B (enExample) 1984-10-02
SG1989G (en) 1989-06-02
EP0110755A1 (fr) 1984-06-13
FR2535721A1 (fr) 1984-05-11
PT77607B (fr) 1986-03-18
ATE22561T1 (de) 1986-10-15
PL140021B1 (en) 1987-03-31
NO159852B (no) 1988-11-07
EP0110755B1 (fr) 1986-10-01
ZA838065B (en) 1984-06-27
FI79536C (fi) 1990-01-10
FI834087L (fi) 1984-05-09
SU1333238A3 (ru) 1987-08-23
FI79536B (fi) 1989-09-29
CS244681B2 (en) 1986-08-14
KR840006641A (ko) 1984-12-01
PL139946B1 (en) 1987-03-31
AU2089883A (en) 1984-05-17
IE56209B1 (en) 1991-05-22
PH20421A (en) 1987-01-05
ES527091A0 (es) 1984-07-01
NO834057L (no) 1984-05-09
PL140992B1 (en) 1987-06-30
YU221183A (en) 1986-06-30
SU1316558A3 (ru) 1987-06-07
DD219770A5 (de) 1985-03-13
NZ206177A (en) 1985-11-08
DD229407A5 (de) 1985-11-06
FR2535721B1 (enExample) 1985-05-17
NO159852C (no) 1989-02-15
DE3366623D1 (en) 1986-11-06
DK511383A (da) 1984-05-09
IE832581L (en) 1984-05-08
US4721710A (en) 1988-01-26
DK511383D0 (da) 1983-11-08
PL249750A1 (en) 1985-03-12
ES8406070A1 (es) 1984-07-01
IL70099A (en) 1987-10-20
IL70099A0 (en) 1984-01-31
AU565519B2 (en) 1987-09-17
OA07582A (fr) 1985-03-31
YU184285A (en) 1986-06-30
JPS59161377A (ja) 1984-09-12
PL244462A1 (en) 1985-02-13
SU1333237A3 (ru) 1987-08-23
PT77607A (fr) 1983-12-01
KR900006721B1 (ko) 1990-09-20
FI834087A0 (fi) 1983-11-08
MA19948A1 (fr) 1984-07-01

Similar Documents

Publication Publication Date Title
DE69200685T2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
HU191494B (en) Process for producing of pipridindion derivatives and medical products consisting of such preparates
HU187868B (en) Process for producing dihydropyridine derivatives
US4374841A (en) Pyridoxine derivatives, and use in therapeutics
HU199425B (en) Process for producing alpha-alkyl-/4-amino-3-quinolinyl/-methanols and 1-square brackets open 4-/aralkylamino/-3-quinolinyl square brackets closed -alkanones, as well as pharmaceutical compositions comprising such compounds as active ingredient
JPH02138262A (ja) 新規医薬活性１，２，３，４，４ａ，５，１０，１０ａ‐オクタヒドロ‐ベンゾ〔ｇ〕キノリン誘導体
JPS6222985B2 (enExample)
AU764388B2 (en) New substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them
US4868194A (en) Imidazole antiarrhythmics
US4758577A (en) 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders
HU185432B (en) Process for producing indene derivatives
CS203940B2 (en) Process for preparing aryloktahydropyridines
FR2750991A1 (fr) Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
EP0050072B1 (fr) Nouvelles cyclopropylméthyl pipérazines, leur procédé de préparation et leur application en thérapeutique
NL8004003A (nl) Chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen.
FR2702211A1 (fr) Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
JPH0115501B2 (enExample)
US3423415A (en) 4 - (n - (3,3 - diphenyl - propyl) - amino) - 1-methyl-3-phenyl-piperidine and intermediates thereto
US4542134A (en) Derivatives of γ-butyrolactone with an anti-arrythmic activity and compositions
US3681361A (en) Disubstituted phenyl-4-piperidones
HU191585B (en) Process for producing tetramethyl-proline-3-carboxamide derivatives and new cardiotherapeutic compositions containing them
HU183292B (en) Process for producing pyrrol-derivatives of myocardium-protecting, antiarrhythmic and thromaocite-aggregation-inhibiting activity and pharmaceutical compositions containing them as active agents
CS244695B2 (cs) Způsob přípravy derivátů 2,6-piperidíndionu
JPWO1998045264A1 (ja) ピペリジンカルボン酸アミド誘導体の製造方法
JPWO1999032446A1 (ja) 新規ジヒドロピリジン誘導体

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee